Purchases and Sales Made in Q3 2024 in Cullinan Oncology, Inc. (CGEM)
This table provides information about the institutional ownership of Cullinan Oncology, Inc. (CGEM) during Q3 2024. The information is specifically focused on institutions that hold shares of Cullinan Oncology, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2024
Q3 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-75.4K- 78.1% |
$1.21M - $1.57M
|
21.2K
$285K
|
|
|
Nov 14, 2024
Q3 2024
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-77.6K- 6.76% |
$1.24M - $1.62M
|
1.07M
$14.4M
|
|
|
Nov 14, 2024
Q3 2024
|
Nextech Invest Ag
|
SELL
|
- |
-80K- 6.55% |
$1.28M - $1.67M
|
1.14M
$15.3M
|
|
|
Nov 14, 2024
Q3 2024
|
Pfm Health Sciences, LP
San Francisco, CA |
SELL
|
- |
-113K- 38.25% |
$1.82M - $2.36M
|
183K
$2.46M
|
|
|
Nov 14, 2024
Q3 2024
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-130K- 11.0% |
$2.09M - $2.72M
|
1.05M
$14.2M
|
|
|
Nov 13, 2024
Q3 2024
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-140K- 33.18% |
$2.24M - $2.92M
|
282K
$3.79M
|
|
|
Nov 14, 2024
Q3 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-153K- 72.12% |
$2.46M - $3.2M
|
59.2K
$797K
|
|
|
Nov 14, 2024
Q3 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-165K- 19.67% |
$2.64M - $3.44M
|
673K
$9.06M
|
|
|
Nov 12, 2024
Q3 2024
|
Franklin Resources Inc
San Mateo, CA |
SELL
|
- |
-253K- 10.35% |
$4.05M - $5.27M
|
2.19M
$29.5M
|
|
|
Nov 14, 2024
Q3 2024
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
SELL
|
- |
-877K- 39.28% |
$14.1M - $18.3M
|
1.36M
$18.2M
|
|
|
Nov 14, 2024
Q3 2024
|
Avidity Partners Management LP
Dallas, TX |
SELL
|
- |
-1.13M- 72.75% |
$18.2M - $23.7M
|
425K
$5.72M
|